Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

L.A. McKeown

May 30, 2025

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Conference News ACC 2022

Managing AF Patients Undergoing PCI—Some Lingering Questions

Michael O'Riordan

April 12, 2022

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Conference News ESC 2019

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

Shelley Wood

September 01, 2019

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

L.A. McKeown

November 27, 2018

News Conference News AHA 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Michael O'Riordan

November 11, 2018

News Conference News ESC 2016

Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC

Todd Neale

August 28, 2016

News Daily News

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

L.A. McKeown

February 09, 2016

News Conference News ESC 2015

Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients

L.A. McKeown

September 01, 2015

Presentation ESC 2015

Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up

Presenter: Gilles Montalescot

August 30, 2015

News Conference News ESC 2015

ALBATROSS: Aldersterone Blockade Fails to Improve Outcomes in Acute MI

Caitlin E. Cox

August 30, 2015

News Conference News ACC 2015

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Todd Neale

March 17, 2015

News Conference News ESC 2014

Another Strike Against Thrombectomy in 1-Year TASTE Results

Todd Neale

September 02, 2014

News Conference News ESC 2014

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Yael L. Maxwell

September 01, 2014

Presentation

Early Eplerenone Treatment in Patients with Acute STEMI Without HF: The REMINDER Study

Presenter: 140896|Gilles Montalescot

May 05, 2014

News Daily News

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart Failure

May 05, 2014

Presentation TCT 2013

Self-Expanding Stents Provide a Real Benefit During STEMI Intervention!

Presenter: Gilles Montalescot

October 31, 2013

Presentation TCT 2013

Aldosterone Antagonism After MI

Presenter: Gilles Montalescot

October 27, 2013

Advertisement

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Managing AF Patients Undergoing PCI—Some Lingering Questions

Recurrent Events Common Among Young Patients With CAD

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients

Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up

ALBATROSS: Aldersterone Blockade Fails to Improve Outcomes in Acute MI

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Another Strike Against Thrombectomy in 1-Year TASTE Results

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Early Eplerenone Treatment in Patients with Acute STEMI Without HF: The REMINDER Study

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart Failure

Self-Expanding Stents Provide a Real Benefit During STEMI Intervention!

Aldosterone Antagonism After MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content